- Barrons.com•29 days ago
It was another tough week for biotech, writes Raymond James's Christopher Raymond and his team, as 'significant' outflows from the sector were on display for a second straight week. Biotech outflows totaled roughly $733 million in the week ended January 25, which translated to a 1.49% decrease in assets. Last week the 'all equities' category also saw outflows equivalent to a 0.1% decrease in assets, also a second week of outflows for the category.
- Investopedia•last month
Biotech sector stocks surged after the election, but pulled back when Trump targeted drug companies.
- Barrons.com•2 months ago
Last year was a difficult one for many healthcare investors, and uncertainty about the new administration’s agenda fueled short sale activity as the year drew to a close, according to data from S3 Partners. As for industries in healthcare, Alexion Pharmaceuticals (ALXN), which was also the most shorted stock in the sector, was the stock with the largest short interest in biotech, Stryker (SYK) in equipment and services, UnitedHealth (UNH) in providers and services, Cerner (CERN) in technology, Illumina (ILMN) in life science tools and services, and Allergan (AGN) in pharmaceuticals.
BIB : Summary for ProShares Ultra Nasdaq Biotechn - Yahoo Finance
ProShares Ultra Nasdaq Biotechnology (BIB)
NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
|Bid||49.19 x 500|
|Ask||51.70 x 200|
|Day's Range||47.11 - 50.08|
|52 Week Range||33.97 - 52.80|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||N/A|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|